Compare Ovintiv Inc. (DE) (OVV) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ovintiv Inc. (DE) vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Ovintiv Inc. (DE) trades at $64.14 (market cap $17.53B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.73 (market cap $2.27B). The key difference: Ovintiv Inc. (DE) is far larger — about 7.7× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Ovintiv Inc. (DE) pays a 1.89% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| OVV | SLS | |
|---|---|---|
Market Cap | $17.53B | $2.27B |
Volume | 3,002,714 | 4,179,659 |
Sector | Energy | Health |
52-Week High | $66.97 | $15.46 |
52-Week Low | $35.97 | $1.39 |
Typical Hold Time | 1 Days | — |
Enterprise Value | $21.86B | $2.14B |
Dividend Yield | 1.89% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ovintiv Inc. (DE)
Ovintiv explores for and produces oil and natural gas in North America. Its operations are concentrated in major U.S. and Canadian resource basins.
Read more on OVV →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
